Skip to main content

Hidradenitis Suppurativa Content

Quizzes
Test your knowledge of the North American Clinical Guidelines for Hidradenitis Suppurativa.
Conferences
Dr Patel-Cohen shared clinical pearls and discussed the latest advances in the treatment of hidradenitis suppurativa. She presented on this topic at the virtual Interdisciplinary Autoimmune Summit 2020.
News
Findings from a recent study showed patients with hidradenitis suppurativa experienced significant delays in receiving a diagnosis, and these delays were associated with more severe disease burden.
News
A recent poster study, presented at AAD VMX 2020, showed that adalimumab effectively reduced hidradenitis suppurativa activity among patients at an outpatient dermatology center.
News
Findings from a recent study showed major depressive disorder was associated with an increased risk of autoimmune skin diseases, including hidradenitis suppurativa.
News
Findings from a recent study indicated that several comorbidities precede a diagnosis of hidradenitis suppurativa, and that several develop afterwards.
News
Findings from an open label cohort study showed treatment of moderate to severe hidradenitis suppurativa with an IL-17 inhibitor was associated clinical response and had a favorable safety profile.
News
Findings from a recent study showed a potential association between birth weight and childhood weight and the risk of developing hidradenitis suppurativa in adulthood.
News
In a recent study, researchers assessed the prevalence of inflammatory eye disease and treatment outcomes among patients with hidradenitis suppurativa.
News
A recent systemic review showed patients with hidradenitis suppurativa who underwent partial excision had higher recurrence rates compared with wide excision.
Back to Top